Stryker Corp
SYKNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 19/3024% below fair value
$306.81+14.95 (+5.12%)
Close on Nov 2, 2026Market cap $117.68BP/E 32.7Yield –
Stryker Full-Year Guidance Issued in Quarter by Quarter
Full-Year Guidance Issued in Quarter — Organic Net Sales Growth Low End (%) (%)
Stryker Full-Year Guidance Issued in Quarter: 6.5% in Q3 2026.
Latest, Q3 2026
6.5%
Period ended Sep 30, 2026
Change on a year earlier
–
History
25 quarters
Since Q2 2017
Sources
25
Documents cited below
Where the Q3 2026 figure comes from
“expect organic net sales growth (2) in the range of 6.5% to 7.0%”
Reported in Stryker Form 8-K Quarterly Earnings Releases (Outlook).
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up full-Year Guidance Issued in Quarter
Cite this data
StockData. (2026). Stryker Full-Year Guidance Issued in Quarter (%), quarterly Q2 2017–Q3 2026 [Data set]. Compiled from Stryker SEC filings and investor materials. https://stockdatahq.com/stocks/syk/kpis/core-guid-org-low
See every metric in the Stryker KPI table. Data updated Nov 2, 2026.